- Trials with a EudraCT protocol (2,083)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,083 result(s) found for: Secondary health care.
Displaying page 1 of 105.
EudraCT Number: 2018-001328-21 | Sponsor Protocol Number: ABR65448 | Start Date*: 2019-01-08 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Chronotherapy with aspirin for reduction of cardiovascular disease | ||
Medical condition: The medical condioton to be investigated is recurrent cardiovascular disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002853-21 | Sponsor Protocol Number: RGHT000405 | Start Date*: 2007-09-03 |
Sponsor Name:Belfast Health & Social Care Trust [...] | ||
Full Title: A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults | ||
Medical condition: Colonization with methicillin-resistant Staphylococcus aureus (MRSA) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-000124-14 | Sponsor Protocol Number: NL47077 | Start Date*: 2014-10-21 |
Sponsor Name:Academic Medical Center | ||
Full Title: Antibiotic prophylaxis to prevent wound infections following implant removal after foot, ankle and lower leg fractures. | ||
Medical condition: Postoperative wound infection following implant removal below the knee | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002411-29 | Sponsor Protocol Number: M13-045 | Start Date*: 2012-04-26 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: An Open-Label Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting. | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) ES (Completed) GB (Completed) DE (Completed) BE (Completed) DK (Completed) GR (Completed) PT (Completed) AT (Completed) IE (Completed) IT (Completed) FI (Completed) CZ (Completed) SK (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000905-24 | Sponsor Protocol Number: 25052004 | Start Date*: 2005-02-08 |
Sponsor Name:University of York | ||
Full Title: Cryotherapy versus salicylic acid for the treatment of verrucae: a randomised controlled trial. | ||
Medical condition: Verrucae | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004424-65 | Sponsor Protocol Number: 15085MS-AS | Start Date*: 2016-05-09 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: Prevention of post-operative complications by using HMG-CoA Reductase Inhibitor in patients undergoing oesophagectomy - A multicentre, randomised, double blind, placebo controlled trial | ||
Medical condition: Post-operative complications - Post-operative Pulmonary complication, Acute Respiratory Distress Syndrome and Myocardial Infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2009-015659-26 | Sponsor Protocol Number: 2009-015659-26 | Start Date*: 2010-01-22 | |||||||||||||||||||||
Sponsor Name:Karolinska Institutet | |||||||||||||||||||||||
Full Title: Cortical and hormonal stress responses to pain management with morphine in standard clinical dosage | |||||||||||||||||||||||
Medical condition: Neonatal pain | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001366-11 | Sponsor Protocol Number: Solidarity | Start Date*: 2020-03-27 |
Sponsor Name:FIB-HCSC [...] | ||
Full Title: An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Temporarily Halted) LT (Completed) IE (Completed) IT (Completed) PT (Completed) SK (Completed) RO (Prematurely Ended) LV (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004588-11 | Sponsor Protocol Number: ABR64005 | Start Date*: 2019-09-10 |
Sponsor Name:University Maastricht | ||
Full Title: Control Crohn Safe Trial: Long term efficacy and safety of periodic treatment with adalimumab versus standard step-care for newly diagnosed Crohn's disease. | ||
Medical condition: The chronic inflammatory bowel disease Crohn's disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003556-31 | Sponsor Protocol Number: SHP-607-201 | Start Date*: 2015-02-10 |
Sponsor Name:Premacure AB, A Member of the Shire Group of Companies | ||
Full Title: Long-term Outcome of Children Enrolled in Study ROPP-2008-01 Previously Treated with rhIGF-1/rhIGFBP-3 for the Prevention of Retinopathy of Prematurity (ROP) or Who Received Standard Neonatal Care | ||
Medical condition: Retinopathy of Prematurity (ROP) | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) GB (GB - no longer in EU/EEA) NL (Completed) PL (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003976-36 | Sponsor Protocol Number: CBPD952ABE02 | Start Date*: 2006-09-01 |
Sponsor Name:Professor Anita Leys - Dienst Oftalmologie UZ St. Rafaël | ||
Full Title: An academic monocenter study assessing the safety and efficacy of Lucentis (ranizumab 0.3 mg) administered in conjunction with photodynamic therapy with Visudyne in patients with occult or predomi... | ||
Medical condition: Male and female patients ≥50 years of age with subfoveal choroidal neovascularisation lesions secondary to age related macular degeneration, either predominantly classic or occult with no classic c... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019513-24 | Sponsor Protocol Number: 10_022 | Start Date*: 2011-03-03 |
Sponsor Name:London School of Hygiene & Tropical Medicine | ||
Full Title: Antibiotics for exacerbations of chronic obstructive pulmonary disease: a pilot randomised trial within the General Practice Research Database | ||
Medical condition: Diagnosed at a GP visit as suffering from acute exacerbation of COPD a. Medical history of COPD b. Increase in dyspnoea AND increase of (non-purulent) sputum volume | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001492-33 | Sponsor Protocol Number: CGE_2020_9 | Start Date*: 2020-04-10 |
Sponsor Name:Hôpital Fondation Adolphe de Rothschild | ||
Full Title: Interest in the administration of Dornase alpha aerosol in ARDS secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19 | ||
Medical condition: Patients on mechanical ventilation, inpatient resuscitation for ARDS, secondary to COVID-19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001769-27 | Sponsor Protocol Number: CHI0465 | Start Date*: 2008-09-29 |
Sponsor Name:Southampton University Hospital Trust | ||
Full Title: Microbiological assessment of prophylactic ciprofloxacin therapy for children with cystic fibrosis during viral respiratory viral infection to prevent Pseudomonas aeruginosa colonisation – a random... | ||
Medical condition: Cystic Fibrosis Specifically the trial will include children aged 2-14 years with a diagnosis of cystic fibrosis and not chronically infected with pseudomonas aeruginosa in their lungs. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002471-18 | Sponsor Protocol Number: | Start Date*: 2019-01-18 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: The clinical effectiveness and cost effectiveness of clozapine for inpatients with borderline personality disorder: randomised controlled trial | |||||||||||||
Medical condition: Borderline Personality Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001965-17 | Sponsor Protocol Number: AITT2013/5 | Start Date*: 2013-09-26 | |||||||||||
Sponsor Name:Debreceni Egyetem Orvos- és Egészségtudományi Centrum Aneszteziológiai és Intenzív Terápiás Tanszék | |||||||||||||
Full Title: Incidence of postoperative residual neuromuscular blockade following the administration of rocuronium: A randomized placebo controlled study. | |||||||||||||
Medical condition: The effect of sugammadex and neostigmin on postoperative residual neuromuscular blockade will be investigated, therefore the patients suffering from various conditions undergoing surgery in general... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001051-12 | Sponsor Protocol Number: 11RM013 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Nottingham University Hospitals NHS Trust | |||||||||||||
Full Title: Early low dose steroids for adults admitted to hospital with influenza-like illness during a pandemic: a randomised placebo controlled trial | |||||||||||||
Medical condition: Influenza-like illness | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004552-64 | Sponsor Protocol Number: 131016 | Start Date*: 2017-07-03 |
Sponsor Name:Center for Digestive Diseases, Karolinska University Hospital | ||
Full Title: MISTRAL - Mistletoe therapy in primary and recurrent inoperable pancreatic cancer - A phase III prospective, randomized, double blinded, multicenter, parallel group, placebo controlled clinical tr... | ||
Medical condition: Primary or recurrent inoperable pancreatic cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001950-33 | Sponsor Protocol Number: 15/0592 | Start Date*: 2018-01-19 | |||||||||||
Sponsor Name:UCL | |||||||||||||
Full Title: Methylphenidate versus placebo for fatigue in advanced cancer (MePFAC) | |||||||||||||
Medical condition: Cancer-related fatigue | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001307-16 | Sponsor Protocol Number: SIC | Start Date*: 2020-04-01 |
Sponsor Name:Fundación para la Investigación Biomédica Hospital Ramón y Cajal | ||
Full Title: Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to COVID-19. | ||
Medical condition: Adult respiratory distress syndrome (ARDS) secondary to SARS-CoV-2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
